Granules Metformin Recall Lawsuit

What’s the Problem?

This recall affects 12 lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count, according to the U.S. Food & Drug Administration (FDA).

Granules Pharmaceuticals issued the recall after routine testing showed NDMA levels above the FDA Acceptable Daily Intake (ADI) Limit.

Animal studies have linked NDMA to liver, lung, and kidney cancer. The World Health Organization (WHO) says it can also cause gastric or colorectal cancer.

If you were prescribed any metformin that is included in this recall, you should contact Granules Pharmaceuticals for information about a return/replacement. Anyone concerned about a potential adverse reaction to NDMA in metformin should consult their physician.

This recall began on July 3, 2020.

Do I Have a Granules Metformin Recall Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Granules Metformin Recall Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

If you or a loved one was diagnosed with cancer after taking recalled metformin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.